Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor

Journal of Virology

Volumn 75, Issue 2, 2001, Pages 726-737

  Holmen, S L ^a   Melder, D C ^a   Federspiel, M J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TVA RECEPTOR; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; CHICKEN; GENE MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUAIL; RECEPTOR BINDING; VIRUS INFECTIVITY;

AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; AVIAN LEUKOSIS; AVIAN LEUKOSIS VIRUS; AVIAN PROTEINS; CELL LINE; CELLS, CULTURED; CHICKENS; CLONING, MOLECULAR; IMMUNOGLOBULIN G; MICE; MOLECULAR SEQUENCE DATA; MUTATION; QUAIL; RECEPTORS, VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 0035158622     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.2.726-737.2001     Document Type: Article

References (72)

1. Identification of a cellular receptor for subgroup E avian leukosis virus
2. Identification and characterization of a shared TNFR-related receptor for subgroup B, D and E avian leukosis viruses reveal cysteine residues required specifically for subgroup E viral entry
3. Endogenous viral genes are non-essential in the chicken
4. HPRS-103 (exogenous avian leukosis virus, subgroup J) has an env gene related to those of endogenous elements EAV-0 and E51 and an E element found previously only in sarcoma viruses
5. Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptor
6. Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation
7. Genetic mapping of the cloned subgroup A avian sarcoma and leukosis virus receptor gene to the TVA locus
8. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor
9. Importance of cysteines in the LDLR-related domain of the subgroup A avian leukosis and sarcoma virus receptor for viral entry
10. Retroviral vectors preloaded with a receptor-ligand bridge protein are targeted to specific cell types
11. Env genes of avian retroviruses: Nucleotide sequence and molecular recombinants define host range determinants
12. The avian retrovirus env gene family: Molecular analysis of host range and antigenic variants
13. CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis
14. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells
15. Genetic diversity and evolution of retroviruses
16. A soluble form of a receptor for subgroup A avian leukosis and sarcoma viruses (ALSV-A) blocks infection and binds directly to ALSV-A
17. Soluble receptor-induced retroviral infection of receptor-deficient cells
18. Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunits
19. Receptor-triggered membrane association of a model retroviral glycoprotein
20. A soluble form of CD4 (T4) protein inhibits AIDS virus infection
21. Determinants for receptor interaction and cell killing on the avian retrovirus glycoprotein gp85
22. Molecular basis of host range variation in avian retroviruses
23. Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype
24. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent SIV strain
25. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4
26. Expression of avian reticuloendotheliosis virus envelope confers host resistance
27. Retroviral gene delivery
28. Retroviral infection coupled with tissue transplantation limits gene transfer in the chicken embryo
29. A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retina
30. HIV infection is blocked in vitro by recombinant soluble CD4
31. The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein
32. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein
33. Presence of a hypervariable region within the hr2 domain of the host range determining sequences of the envelope glycoprotein gp85 (SU) of subgroup-A avian sarcoma-leukosis viruses
34. Activation of a retroviral membrane fusion protein: Soluble receptor-induced liposome binding of the ALSV envelope glycoprotein
35. The DF-1 chicken fibroblast cell line: Transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses
36. Stable exposure of the coreceptor binding site in a CD4-independent HIV-1 envelope protein
37. Selection of a subgroup A avian leukosis virus [ALV(A)] envelope resistant to soluble ALV(A) surface glycoprotein
38. Soluble forms of the subgroup A avian leukosis virus [ALV(A)] receptor Tva signifcantly inhibit ALV(A) infection in vitro and in vivo
39. Viral entry and receptors
40. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation
41. Neutralization of poliovirus by cell receptors expressed in insect cells
42. Poliovirus mutants resistant to neutralization with soluble cell receptors
43. Introduction of DNA into eukaryotic cells
44. Soluble CD4 and CD4 immunoglobulin-selected HIV-1 variants: A phenotypic characterization
45. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity
46. A soluble form of intercellular adhesion molecule-1 inhibits rhinoviras infection
47. Recombinant CD4-selected human immunodeficiency virus type 1 variants reduced gp120 affinity for CD4 and increased cell fusion capacity
48. Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail
49. Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection
50. Identification of residues in alpha-macroglobulins important for binding to the α2-macroglobulin receptor/low density lipoprotein receptor-related protein
51. Analysis of the subgroup A avian sarcoma and leukosis virus receptor: The 40-residue, cysteine-rich, low-density lipoprotein receptor repeat motif of Tva is sufficient to mediate viral entry
52. Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection
53. Conversion of a human low-density lipoprotein receptor ligand-binding repeat to a virus receptor: Identification of residues important for ligand specificity
54. Characterization of determinants for envelope binding and infection in Tva, the subgroup A avian sarcoma and leukosis virus receptor
55. Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants
56. The EV-0-derived cell line DF-1 supports efficient replication of avian leukosis-sarcoma viruses and vectors
57. Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells
58. Blocking of HIV infectivity by a soluble, secreted form of the CD4 antigen
59. An enzyme-linked immunoabsorbant assay for detecting avian leukosis sarcoma viruses
60. Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein
61. Selection of an avian retrovirus mutant with extended receptor usage
62. Soluble CD4 molecules neutralize human immunodeficiency virus type 1
63. Recombinants between endogenous and exogenous avian tumor viruses: Role of the C region and other portions of the genome in the control of replication and transformation
64. Mutant and recombinant avian retroviruses with extended host range
65. Cellular receptors and viral glycoproteins involved in retrovirus entry
66. Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis viruses
67. Cell killing by avian leukosis viruses
68. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E
69. Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses
70. An avian sarcoma/leukosis virus-based gene trap vector for mammalian cells
71. Identification and characterization of the viral interaction determinant of the subgroup A avian leukosis virus receptor
72. Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses